Kobo Biotech has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 13th February, 2023, to consider and approve the Unaudited Financial Results along with the Limited Review Report for the quarter and nine-months ended December 31, 2022.
The above information is a part of company’s filings submitted to BSE.